Document Detail


Chronic lymphocytic leukaemia: up-dated recommendations on diagnosis and treatment.
MedLine Citation:
PMID:  15007256     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diagnosis and treatment of chronic lymphatic leukaemia (CLL) are currently undergoing great change. New knowledge of prognosis factors and the numerous new therapeutic procedures now available, such as purine analogues, high-dose treatment and monoclonal antibodies are making major contributions to this progress. As a consequence, the options for treatment of CLL are considerably more diverse now than a few years ago, and now include procedures that take into account age and risk. At the same time, it should be emphasized that many important questions regarding the treatment of CLL remain unresolved. It is anticipated that these questions will be answered over the coming few years by including patients in multicentre studies like those being carried out by the German CLL study group.
Authors:
M Hallek; M Bergmann; B Emmerich
Related Documents :
19608006 - Should epidural drain be recommended after supratentorial craniotomy for epileptic pati...
17634496 - Impact of primary prophylaxis with granulocyte colony-stimulating factor on febrile neu...
19863336 - Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymp...
2458686 - Cerebrospinal fluid concentrations of substance p and (met)enkephalin-arg6-phe7 during ...
16239186 - Does the type of prosthesis influence the incidence of permanent pacemaker implantation...
20838356 - The effect of cardiopulmonary bypass on the hypothalamic-pituitary-adrenal axis in chil...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Onkologie     Volume:  27     ISSN:  0378-584X     ISO Abbreviation:  Onkologie     Publication Date:  2004 Feb 
Date Detail:
Created Date:  2004-03-09     Completed Date:  2004-07-07     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7808556     Medline TA:  Onkologie     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  97-104     Citation Subset:  IM    
Copyright Information:
Copyright 2004 S. Karger GmbH, Freiburg
Affiliation:
Klinik I für Innere Medizin, Universität Köln, Germany. michael.hallek@uni-koeln.de
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / adverse effects,  therapeutic use*
Disease Progression
Dose-Response Relationship, Drug
Humans
Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis,  drug therapy*,  mortality,  pathology
Multicenter Studies as Topic
Neoplasm Staging
Prognosis
Randomized Controlled Trials as Topic
Stem Cell Transplantation
Survival Rate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  ICOS: a new costimulatory ligand/receptor pair and its role in T-cell activion.
Next Document:  Peripheral venous thrombosis in children and adolescents with adipsic hypernatremia secondary to hyp...